Lessons learned from Ebola Vaccine R&D during a public health emergency
In spite of a complete lack of Research and Development (R&D) preparedness, the 2013-2016 West-Africa Ebola experience demonstrated that it is possible to compress R&D timelines to less than a single year, from a more usual decade or longer. This is mostly to be credited to an unprecedented...
Saved in:
Main Author: | Marie-Paule Kieny (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
From vaccines to global health to vaccines
by: Marie-Paule Kieny
Published: (2018) -
The 2014 Ebola outbreak: ethical use of unregistered interventions
by: Ruediger Krech, et al.
Published: (2014) -
Health-system resilience: reflections on the Ebola crisis in western Africa
by: Marie-Paule Kieny, et al.
Published: (2014) -
Managing emerging transnational public health security threats: lessons learned from the 2014 West African Ebola outbreak
by: Aaron M. Wendelboe, et al.
Published: (2018) -
Lessons learned from engaging communities for Ebola vaccine trials in Sierra Leone: reciprocity, relatability, relationships and respect (the four R's)
by: Sara Dada, et al.
Published: (2019)